Clinical Trials Logo

Clinical Trial Summary

The purpose of the study was to evaluate ovicidal efficacy of a single application of abametapir lotion 0.74% w/w intended for the treatment of head lice.


Clinical Trial Description

This was a double-blind, randomised, vehicle-controlled, parallel group study in males and females, aged three years and older with active head lice infestation. The study was designed to assess the ovicidal efficacy of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at the study site. This study used an ex vivo method of assessment for ovicidal efficacy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02097485
Study type Interventional
Source Dr. Reddy's Laboratories Limited
Contact
Status Completed
Phase Phase 2
Start date May 2014
Completion date October 2014

See also
  Status Clinical Trial Phase
Recruiting NCT04878276 - Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
Completed NCT01907490 - Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation Phase 2
Completed NCT02062060 - Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation Phase 3
Completed NCT02060903 - A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation Phase 3
Recruiting NCT06057506 - Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation N/A
Completed NCT02010333 - A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation Phase 2